SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001571049-14-004801
Filing Date
2014-09-24
Accepted
2014-09-24 17:02:25
Documents
3
Effectiveness Date
2014-09-24

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE ADDITIONAL MATERIALS t1401810_defa14a.htm DEFA14A 23665
2 GRAPHIC logo.jpg GRAPHIC 22756
3 GRAPHIC sg_thomas-dagger.jpg GRAPHIC 19312
  Complete submission text file 0001571049-14-004801.txt   83116
Mailing Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666
Business Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666 201-329-7300
PHIBRO ANIMAL HEALTH CORP (Filer) CIK: 0001069899 (see all company filings)

IRS No.: 131840497 | State of Incorp.: DE | Fiscal Year End: 0630
Type: DEFA14A | Act: 34 | File No.: 001-36410 | Film No.: 141118849
SIC: 2834 Pharmaceutical Preparations